1. Van Allen MW, Frohlich JA, Davis JR. Inherited predisposition to generalized amyloidosis. Neurology. 1969;19:10–25.
2. Nichols WC, Dwulet FE, Liepnieks J, Benson MD. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun. 1988;156:762–68.
3. Vigushin DM, Gough J, Allan D, Alguacil A, Penner B, Pettigrew NM, et al. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. Q J Med. 1994;87:149–54.
4. Rader DJ, Gregg RE, Meng MS, Schaefer Jr, Kindt MR, Zech LA. In vivo metabolism of a mutant apolipoprotein, apoAI Iowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res. 1992;33:755–63.
5. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics. 1990;8:318–23.